Skip to Content
Merck
CN
  • Meningeal lymphatics clear erythrocytes that arise from subarachnoid hemorrhage.

Meningeal lymphatics clear erythrocytes that arise from subarachnoid hemorrhage.

Nature communications (2020-06-24)
Jinman Chen, Linmei Wang, Hao Xu, Lianping Xing, Zixin Zhuang, Yangkang Zheng, Xuefei Li, Chinyun Wang, Shaohua Chen, Zibin Guo, Qianqian Liang, Yongjun Wang
ABSTRACT

Extravasated erythrocytes in cerebrospinal fluid (CSF) critically contribute to the pathogenesis of subarachnoid hemorrhage (SAH). Meningeal lymphatics have been reported to drain macromolecules and immune cells from CSF into cervical lymph nodes (CLNs). However, whether meningeal lymphatics are involved in clearing extravasated erythrocytes in CSF after SAH remains unclear. Here we show that a markedly higher number of erythrocytes are accumulated in the lymphatics of CLNs and meningeal lymphatics after SAH. When the meningeal lymphatics are depleted in a mouse model of SAH, the degree of erythrocyte aggregation in CLNs is significantly lower, while the associated neuroinflammation and the neurologic deficits are dramatically exacerbated. In addition, during SAH lymph flow is increased but without significant lymphangiogenesis and lymphangiectasia. Taken together, this work demonstrates that the meningeal lymphatics drain extravasated erythrocytes from CSF into CLNs after SAH, while suggesting that modulating this draining may offer therapeutic approaches to alleviate SAH severity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Latex beads, amine-modified polystyrene, fluorescent red, aqueous suspension, 1.0 μm mean particle size
Sigma-Aldrich
Fluoroshield with DAPI, histology mounting medium
Sigma-Aldrich
VEGFR3 Kinase Inhibitor, MAZ51, The VEGFR3 Kinase Inhibitor, MAZ51, also referenced under CAS 163655-37-6, controls the biological activity of VEGFR3 Kinase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.